Improving the lives of people with Tourette Syndrome

We are developing a safe and effective non-drug treatment to reduce tics and the urge to tic. This is achieved through gentle stimulation of the median nerve in the wrist.
Neupulse Device
Tourettes Action Logo
"This wearable and self-managing treatment could change the lives of people living with Tourette’s. It potentially offers a flexible and accessible option for the many people who are currently struggling to access treatment in the UK."
Emma McNally, Chief Executive Officer, Tourettes Action

"(The stimulation) is like a sudden relaxed state, the tension you get with the tics and the urges eases, and I feel less on edge"

Natalie Davidson
Natalie tried the stimulation device during a Channel 5 documentary about Tourette’s
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action
Tourettes Friendly Organisation

About us

We will empower individuals with brain health conditions to have a choice over controlling their symptoms.

We use state-of-the-art brain imaging and brain stimulation techniques to investigate the neural processes that give rise to tics, the brain correlates of premonitory urges and the mechanisms of brain plasticity that might lead to the control or reduction of tics.

Our Solutions

Neupulse App
Neutrack App
We are working on the development of a phone app that will monitor Tourette syndrome clinical symptoms over time as well as external factors that may influence these symptoms.
read more ->
Wearable
Wearable Wrist Device
We are developing a wearable wrist device that delivers median nerve stimulation at the press of a button with the aim to give people control of their tics.

read more ->
Research
We aim to understand how the brain networks that give rise to tics could be effectively modified or controlled using non-invasive forms of brain stimulation so as to bring about a reduction in tics.
read more ->

News

More news
Frequently Asked Questions
An important focus of our research over the last few years has been to understand how the brain networks that give rise to tics could be effectively modified or controlled using non-invasive forms of brain stimulation so as to bring about a reduction in tics.

We estimate the device will be available in 2026. As the device will be a medical device, it will have to pass medical regulations, which takes time to develop and validate. In addition, time is required for independent testing houses to test the device, to ensure it is safe and compliant with the standards.

Our research suggests that the stimulation is suitable for anyone over 12 years of age.

The UK-wide double-blind sham-controlled clinical trial of the Neupulse device for suppressing tics in Tourette syndrome run by Neupulse, Nottinghamshire Healthcare NHS Foundation Tust and the University of Nottingham showed that:

People who received active stimulation experienced a significant reduction in the severity and frequency of their tics. On average, they saw a reduction in tic frequency of more than 25% while they received stimulation.

After using the device for 4 weeks, people who received active stimulation experienced a reduction in their tic severity of more than 35%. In total, 59% of the people who received active stimulation experienced a reduction in tic severity of at least 25% compared to baseline.

The clinical trial investigating the effects of median nerve stimulation on Tourette syndrome and associated symptoms has completed recruitment and no more volunteers are required.

Our research investigating the use of median nerve stimulation to reduce tics in Tourette syndrome is a novel approach and there is currently no other clinical trials or similar research going on outside of the UK.

Most definitely. We will be conducting further research on the products we are developing in the future. Please use this link to express your interest and add your details to our Research Mailing List.

Our research team at the University of Nottingham is also continuously conducting research aimed at understanding brain health conditions like Tourette Syndrome and developing new treatment approaches. If you would like to volunteer to take part in these research studies, please take a look at their website

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road
Nottingham 
England
NG7 2TU

Tourettes Friendly Organisation
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action.

Privacy Notice       Cookies

Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Back to Top
crossmenu